Sierra Oncology Inc (SRRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 125,025 | 109,007 | 122,682 | 130,550 | 140,871 |
| TOTAL | $125,800 | $110,350 | $124,504 | $131,093 | $142,617 |
| Non-Current Assets | |||||
| PPE Net | 347 | 400 | 357 | 401 | 623 |
| Other Non-Current Assets | 203 | 223 | 205 | 200 | 196 |
| TOTAL | $550 | $623 | $562 | $601 | $819 |
| Total Assets | $126,350 | $110,973 | $125,066 | $131,694 | $143,436 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,100 | 2,604 | 174 | 734 | 1,779 |
| Accrued Expenses | 4,122 | 5,121 | 13,958 | 6,190 | 5,342 |
| Other current liabilities | N/A | N/A | N/A | N/A | 7 |
| TOTAL | $5,222 | $7,725 | $14,132 | $6,924 | $7,128 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $5,222 | $7,725 | $14,132 | $6,924 | $7,128 |
| Shareholders' Equity | |||||
| Common Shares | 52 | 30 | 30 | 30 | 30 |
| Retained earnings | -593,154 | -582,054 | -572,806 | -557,597 | -544,725 |
| TOTAL | $121,128 | $103,248 | $110,934 | $124,770 | $136,308 |
| Total Liabilities And Equity | $126,350 | $110,973 | $125,066 | $131,694 | $143,436 |